Associations between amino acid levels and autism spectrum disorder severity
- PMID: 40186136
- PMCID: PMC11969702
- DOI: 10.1186/s12888-025-06771-x
Associations between amino acid levels and autism spectrum disorder severity
Abstract
Background: Autism spectrum disorder (ASD) imposes a significant burden on both patients and society. Amino acid metabolism abnormalities are particularly relevant to ASD pathology due to their crucial role in neurotransmitter synthesis, synaptic function, and overall neurodevelopment. This study aims to explore the association between amino acid metabolic abnormalities and the severity of ASD by analyzing the amino acid concentrations in the blood of children with ASD.
Methods: Fasting peripheral blood samples were collected from 344 children with ASD, and amino acid concentrations were measured using liquid chromatography-tandem mass spectrometry (LC-MS/MS) while strictly following quality control measures. The association between amino acid concentrations and ASD severity was evaluated using logistic regression and restricted cubic spline (RCS) analysis. The ROC (receiver operating characteristic) curve, decision curve analysis (DCA), and calibration curve were used to construct and validate predictive models and nomograms, thereby assessing their predictive performance.
Results: Multivariate logistic regression analysis showed that aspartic acid (OR = 1.037, 95% CI: 1.009-1.068, P = 0.01), glutamic acid (OR = 1.009, 95% CI: 1.001-1.017, P = 0.03), phenylalanine (OR = 1.036, 95% CI: 1.003-1.072, P = 0.04), and leucine/isoleucine (OR = 1.021, 95% CI: 1.006-1.039, P = 0.01) were significantly positively correlated with the severity of ASD. On the other hand, tryptophan (OR = 0.935, 95% CI: 0.903-0.965, P < 0.01) and valine (OR = 0.987, 95% CI: 0.977-0.997, P = 0.01) were significantly negatively correlated with the severity of ASD. RCS analysis further revealed a nonlinear relationship between the concentrations of aspartic acid, proline, and glutamic acid and the risk of ASD. ROC curve analysis showed that the combined model achieved an AUC (area under the curve) of 0.806, indicating high diagnostic accuracy. Calibration and decision curve analysis further validated the predictive effectiveness and clinical utility of the model.
Conclusions: This study identifies potential amino acid biomarkers that may contribute to ASD severity assessment. Further research is needed to validate these findings and explore their clinical utility.
Keywords: Amino acid metabolism; Autism spectrum disorder; Early diagnosis; Glutamic acid; Restricted cubic spline analysis; Risk assessment.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: This project was reviewed by the Ethics Committee of the First Affiliated Hospital of Henan University of Chinese Medicine and complies with the relevant provisions of the Measures for the Ethical Review of Biomedical Research Involving Humans and the Declaration of Helsinki regarding human biological experiments. The study protocol has been approved (Approval No.: 2023HL-427-01), and informed consent was obtained from all primary guardians. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests. Clinical trial: Not applicable.
Figures



Similar articles
-
The Association Between Branched-Chain Amino Acid Concentrations and the Risk of Autism Spectrum Disorder in Preschool-Aged Children.Mol Neurobiol. 2024 Aug;61(8):6031-6044. doi: 10.1007/s12035-024-03965-4. Epub 2024 Jan 24. Mol Neurobiol. 2024. PMID: 38265552 Free PMC article.
-
Elevated plasma levels of glutamate in children with autism spectrum disorders.Neuroreport. 2016 Mar 2;27(4):272-6. doi: 10.1097/WNR.0000000000000532. Neuroreport. 2016. PMID: 26825346
-
Identification of Amino Acid Dysregulation as a Potential Biomarker for Autism Spectrum Disorder in China.Neurotox Res. 2020 Dec;38(4):992-1000. doi: 10.1007/s12640-020-00242-9. Epub 2020 Jul 27. Neurotox Res. 2020. PMID: 32719995
-
Decreased levels of urinary free amino acids in children with autism spectrum disorder.J Clin Neurosci. 2018 Aug;54:45-49. doi: 10.1016/j.jocn.2018.05.001. Epub 2018 May 28. J Clin Neurosci. 2018. PMID: 29853226
-
Targeted metabolomics in children with autism spectrum disorder with and without developmental regression.Metab Brain Dis. 2025 Apr 15;40(4):184. doi: 10.1007/s11011-025-01604-y. Metab Brain Dis. 2025. PMID: 40232556
References
-
- Hirota T, King BH. Autism spectrum disorder: A review. JAMA. 2023;329(2):157–68. - PubMed
-
- Lopez MJ, Mohiuddin SS. Biochemistry, essential amino acids. StatPearls. Edn. Treasure Island (FL): StatPearls publishing copyright © 2025. StatPearls Publishing LLC.; 2025.
-
- Shen F, Sergi C. Biochemistry, amino acid synthesis and degradation. edn. Treasure Island (FL): StatPearls publishing copyright © 2025. StatPearls Publishing LLC.; 2025. StatPearls.
-
- García-Cazorla A, Wolf NI, Serrano M, Moog U, Pérez-Dueñas B, Póo P, Pineda M, Campistol J, Hoffmann GF. Mental retardation and inborn errors of metabolism. J Inherit Metab Dis. 2009;32(5):597–608. - PubMed
MeSH terms
Substances
Grants and funding
- 2022JDZX113/Research Project of National Clinical Research Base of Traditional Chinese Medicine of Henan Provincial Health Commission in 2022
- HSRP-DFCTCM-2023-5-08/Henan Province traditional Chinese medicine double first class to create a special project for scientific research in 2023
- 2022BSJJ2001/Doctoral Research Start up Fund of the First Affiliated Hospital of Henan University of Traditional Chinese Medicine in 2022
LinkOut - more resources
Full Text Sources
Medical